Metabolic Syndrome and Long-term Survival Following Liver Resection

Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05568576
Collaborator
(none)
150
1
94.9
1.6

Study Details

Study Description

Brief Summary

Although hepatitis C virus (HCV) infection remains one of the main causes of hepatocellular carcinoma (HCC) worldwide, metabolic syndrome, with its increase in prevalence, has become an important and significant risk factor for HCC

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide. In Egypt, it represents the fourth common cancer. Many hospital-based studies reported increasing the incidence of HCC. The reason for increased incidence could be attributed to (1) improvement in screening programs and diagnostic tools, (2) increasing the survival rate of cirrhotic patients that increases the chance of developing HCC, and (3) increasing the incidence and complications of hepatitis C virus (HCV) which is the most important risk factor in developing liver cancer including HCC in Egypt Precise staging of HCC initially is very useful for determination of the therapeutic options and the overall prognosis of the disease. There are certain clinical features upon which most staging systems use for HCC assessment. These clinical features are size and local extent of the tumor, metastasis of the tumor, severity of the liver disease, and the overall patient performance status Several studies in the United States, Europe, Taiwan, Hong Kong , and New Zealand have examined the potential relationships between various metabolic factors and HCC risks, mostly focusing on type 2 DM and obesity. Diabetes , or even prediabetes, has been observed to be a major metabolic factor related to an increased risk of HCC in individuals with HBV infections.

    There is paucity in literature about effect of metabolic syndrome on Long-term Survival Following Liver Resection for Hepatocellular Carcinoma Among Patients With Chronic Hepatitis C Virus Infection

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Metabolic Syndrome and Long-term Survival Following Liver Resection for Hepatocellular Carcinoma Among Patients With Chronic Hepatitis C Virus Infection
    Actual Study Start Date :
    Jan 1, 2015
    Anticipated Primary Completion Date :
    Nov 30, 2022
    Anticipated Study Completion Date :
    Nov 30, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    patients with HCC underwent resection

    patients with HCC underwent resection

    Outcome Measures

    Primary Outcome Measures

    1. Survival [between two and five years]

      assess frequency long term survival after resection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients with HCC secondary to HCV infection underwent hepatic resection
    Exclusion Criteria:

    HBV patients other modalities of therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ahmed Mohammed Abu-Elfatth Assiut Egypt 71515

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Study Chair: Ahmed Shwakt, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahmed Mohammed Abu Elfatth, Lecturer of Tropical Medicine and Gastroenterology, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05568576
    Other Study ID Numbers:
    • ahmedtoH3
    First Posted:
    Oct 5, 2022
    Last Update Posted:
    Oct 5, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Ahmed Mohammed Abu Elfatth, Lecturer of Tropical Medicine and Gastroenterology, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 5, 2022